Uveitis including Vogt-Koyanagi-Harada syndrome following inactive covid-19 vaccination: a case series.
J Ophthalmic Inflamm Infect
; 13(1): 26, 2023 May 19.
Article
in English
| MEDLINE | ID: covidwho-2326223
ABSTRACT
BACKGROUND:
Currently, large populations have been vaccinated against COVID-19. The whole inactivated Sinopharm COVID-19 vaccine has been the main available COVID-19 vaccine in Iran. Ocular inflammatory reactions have been reported following vaccination. The present case reports aim to introduce four cases of uveitis after the Sinopharm vaccine administration. CASE PRESENTATION Our first reported case is a 38-year-old woman with a positive medical history of inactive ulcerative colitis. Active uveitis had developed following the second dose of the COVID-19 vaccination. The remaining three cases were healthy individuals who developed the first episode of uveitis, after the COVID-19 vaccine administration. Vogt-Koyanagi-Harada syndrome was the final diagnosis in one of the aforementioned cases. All four patients demonstrated favorable responses to corticosteroid treatment.CONCLUSION:
These observations are in line with incoming reports from all around the world and raise concerns about the possibility of post-vaccination uveitis development, especially in cases with a previous history of auto-immune systemic diseases or inactive uveitis.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
J Ophthalmic Inflamm Infect
Year:
2023
Document Type:
Article
Affiliation country:
S12348-023-00347-0
Similar
MEDLINE
...
LILACS
LIS